Transforming Biopharma
Living with myeloma: Patient advocate Yelak Biru’s story
Yelak Biru, president and CEO of the International Myeloma Foundation, is passionate about patient advocacy with good reason—he’s been one himself for 28 years. Yelak joins Maria Whitman to talk about his patient experience and how it shaped his perspective as the leader of the first and largest global organization focusing specifically on multiple myeloma. He also talks about how evolving tools and technology like AI can be used to create personalized patient experience, how his passion for data and analytics informs his work today and the key areas where biopharma can engage to better support patients on their journey.
Yelak Biru, president and CEO of the International Myeloma Foundation, is passionate about patient advocacy with good reason—he’s been one himself for 28 years. Yelak joins Maria Whitman to talk about his patient experience and how it shaped his perspective as the leader of the first and largest global organization focusing specifically on multiple myeloma. He also talks about how evolving tools and technology like AI can be used to create personalized patient experience, how his passion for data and analytics informs his work today and the key areas where biopharma can engage to better support patients on their journey.